Trial · NCT03323749
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Six-minute Walk Test (6MWT) | Elamipretide | Week 4 | 16.243 | Standard Deviation 42.0071 | meters |
| Six-minute Walk Test (6MWT) | Placebo | Week 4 | 7.811 | Standard Deviation 39.5737 | meters |
| Six-minute Walk Test (6MWT) | Elamipretide | Week 12 | 18.286 | Standard Deviation 47.7766 | meters |
| Six-minute Walk Test (6MWT) | Placebo | Week 12 | 8.801 | Standard Deviation 52.1093 | meters |
| Six-minute Walk Test (6MWT) | Elamipretide | Week 24 | 15.330 | Standard Deviation 61.4860 | meters |
| Six-minute Walk Test (6MWT) | Placebo | Week 24 | 17.386 | Standard Deviation 51.6956 | meters |
| Total Fatigue Score on the on the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) | Elamipretide | Week 4 | -1.01 | Standard Deviation 1.714 | score on a scale |
| Total Fatigue Score on the on the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) | Placebo | Week 4 | -1.08 | Standard Deviation 1.865 | score on a scale |
| Total Fatigue Score on the on the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) | Elamipretide | Week 12 | -1.08 | Standard Deviation 1.775 | score on a scale |
| Total Fatigue Score on the on the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) | Placebo | Week 12 | -1.26 | Standard Deviation 2.259 | score on a scale |
| Total Fatigue Score on the on the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) | Elamipretide | Week 24 | -1.18 | Standard Deviation 2.132 | score on a scale |
| Total Fatigue Score on the on the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) | Placebo | Week 24 | -1.09 | Standard Deviation 2.443 | score on a scale |
| Fatigue During Activities Score on the Primary Mitochondrial Disease Symptom Assessment (PMMSA). | Elamipretide | Week 4 | -0.48 | Standard Deviation 0.890 | score on a scale |
| Fatigue During Activities Score on the Primary Mitochondrial Disease Symptom Assessment (PMMSA). | Placebo | Week 4 | -0.60 | Standard Deviation 0.998 | score on a scale |
| Fatigue During Activities Score on the Primary Mitochondrial Disease Symptom Assessment (PMMSA). | Elamipretide | Week 12 | -0.57 | Standard Deviation 0.923 | score on a scale |
| Fatigue During Activities Score on the Primary Mitochondrial Disease Symptom Assessment (PMMSA). | Placebo | Week 12 | -0.67 | Standard Deviation 1.199 | score on a scale |
| Fatigue During Activities Score on the Primary Mitochondrial Disease Symptom Assessment (PMMSA). | Elamipretide | Week 24 | -0.64 | Standard Deviation 1.151 | score on a scale |
| Fatigue During Activities Score on the Primary Mitochondrial Disease Symptom Assessment (PMMSA). | Placebo | Week 24 | -0.59 | Standard Deviation 1.360 | score on a scale |
| Neuro-QoL Fatigue Activities of Daily Living | Elamipretide | Week 4 | -2.5 | Standard Deviation 5.33 | score on a scale |
| Neuro-QoL Fatigue Activities of Daily Living | Placebo | Week 4 | -2.7 | Standard Deviation 5.31 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03323749/results